SHENZHEN, China, July 17 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. , a leading manufacturer and the largest exporter by volume in the Chinese medical dressing industry (medical and wound care products), today announced that it has been notified by the United States Patent and Trademark Office that its method for producing PurCotton(TM) products has been granted a patent.
Mr. Jianquan Li, CEO of Winner Medical, remarked, “We are delighted to receive notice that our unique and innovative PurCotton(TM) production method has been issued an U.S. patent. We believe the patent will build our customers’ confidence in our products and bolster the sales and marketing efforts in the United States.”
The following are specifically covered by the patent: method for producing spunlace non-woven cloth, method for producing spunlace non-woven cloth with X-ray detectable element, spunlace non-woven cloth with X-ray detectable element produced thereby.
As of July 2008, Winner Medical has been granted patents for its PurCotton(TM) product production method in the U.S., China, Singapore, and Russia. The patent application is also pending in other regions such as Europe, Japan, and the Middle East.
Mr. Jianquan Li is the inventor of the patented PurCotton(TM) production method, and he has entered into a licensing agreement with Winner Medical, pursuant to which Mr. Li granted Winner Medical the rights for the use of his patent on a royalty-free basis.
PurCotton(TM) products combine the superior characteristics of both natural cotton and materials made using non-woven technology. It has many advantages over both woven cotton and synthetic non-woven fabric, as it is high quality, natural, safe, strong, durable, healthy and environmentally-friendly. Winner Medical’s patented manufacturing process enables the Company to produce PurCotton(TM) at a lower cost than the woven cotton products, and it can therefore offer customers a lower price without sacrificing its margin. The Company expects the new PurCotton(TM) products to be a growing contributor to its product revenue.
Winner Medical sells PurCotton(TM) products primarily in raw material jumble roll form. It supplies PurCotton(TM) raw materials to manufacturers and providers of consumer hygiene products. Between April 1, 2008 and June, 30, 2008, Winner Medical sold approximately 60 tons of PurCotton(TM) to manufacturers and distributors in Japan, China, the U.S., Korea, and Europe to be made into products such as cosmetic products, disposable diapers and feminine hygiene products.
About Winner Medical
Winner Medical is a leading manufacturer and the largest exporter by volume in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has eight wholly-owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton(TM) products, a non-woven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the U.S. and Japan serving as the top three markets. The Company currently holds 38 patents and patent applications in various products and manufacturing processes and is one of the few Chinese companies licensed with the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the U.S. market. To learn more about Winner Medical, visit Winner Medical’s web site http://www.winnermedical.com .
Forward-Looking Statements
This press release contains certain statements that may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding Winner Medical and its subsidiary companies’ business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical’s periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.
CONTACT: Peng Zhai, Investor Relations Specialist, Winner Medical Group
Inc., +86-755-2806-6858, or peng.zhai@winnermedical.com; Hong Kong, Pamela
Leung of Taylor Rafferty, +852-3196-3712, or
winnermedical@taylor-rafferty.com; United States, Delia Cannan of Taylor
Rafferty, +1-212-889-4350, or winnermedical@taylor-rafferty.com, all for
Winner Medical Group Inc.
Web site: http://www.winnermedical.com/
